The migalastat GLP-HEK assay is the gold standard for determining amenability in patients with Fabry disease

Publication date: September 2019Source: Molecular Genetics and Metabolism Reports, Volume 20Author(s): Raphael Schiffmann, Daniel G. Bichet, Elfrida Benjamin, Xiaoyang Wu, Roberto Giugliani

Source: Molecular Genetics and Metabolism Reports - July 19, 2019 Category: Genetics & Stem Cells Source Type: research